Harry Harper in Totowa, New Jersey

Home New Jersey Totowa

Harry Harper has Hematology/oncology as his primary medical specialty. Their primary office is: 225 Minnisink Rd in Totowa, New Jersey. There is an additional office location, for a total of two, for Harry Harper that can be viewed further down.

They're a part of the: Totowa Cancer Center medical group which has around 3 members. You can call their office at 862-657-4900 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Baylor College Of Medicine and graduated in 1977 (around 47 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Harry David Harper Office Phone and Directions

Harry Harper
Totowa Cancer Center
225 Minnisink Rd
Totowa, New Jersey 07512
862-657-4900

Patient Ratings
Please rate your experience with Harry Harper below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 862-657-4900

Enter a starting address:

Healthcare Info for Harry Harper

Medical School: Baylor College Of Medicine
Graduation Year: 1977
The Primary Medical Specialty for Harry Harper is listed as: Hematology/oncology
Approximate Years of Experience: 47
PAC (PECOS ID)#: 0941285753
NPI #: 1811958481
NPI Created On: 03/31/2006
NPI Last Updated Listed as: 01/26/2022
Primary Taxonomy Code: 207RH0000X
License Number:
25MA04174300
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

AmeriHealth New Jersey
Blue Cross Blue Shield
Humana
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: Spanish, English.

Services and Procedures include:

Complete blood cell count (red cells, white blood cell, platelets), automated test
Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
New patient office or other outpatient visit, typically 60 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 40 minutes
Initial hospital inpatient care, typically 70 minutes per day
Subsequent hospital inpatient care, typically 25 minutes per day
Subsequent hospital inpatient care, typically 35 minutes per day
Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a
Injection, epoetin alfa, (for non-esrd use), 1000 units
Injection, filgrastim (g-csf), excludes biosimilars, 1 microgram
Injection, pegfilgrastim, 6 mg

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788711261

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788711263

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781016997

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781017001

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781016999

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 819105201

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: VERZENIO

Open Associated Drug #1: 0002-6216-54

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 819118051

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: CYRAMZA

Open Associated Drug #1: 0002-7669-01

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: RETEVMO

Associated Drug #2: 0002-2980-60

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 819181269

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: VERZENIO

Open Associated Drug #1: 0002-6216-54

Payments Total: $15

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783610425

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: OPDIVO

Open Associated Drug #1: 0003-3774-12

Payments Total: $1,650

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783610435

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: OPDIVO

Open Associated Drug #1: 0003-3774-12

Additional Office Locations

1. Regional Cancer Care Associates Llc
92 2nd St
Hackensack, NJ 07601
Group Members: 111

Phone: 862-657-4900

Enter a starting address:

Hematology/oncology Professionals in Totowa

1.
Elias Obeid MD

225 Minnisink Rd
Totowa, NJ
Totowa Cancer Center

2.
Donna Mcnamara MD

225 Minnisink Rd
Totowa, NJ
Totowa Cancer Center

Providers in Totowa Cancer Center

1.Harry Harper

225 Minnisink Rd
Totowa Nj 07512-1804
Totowa Cancer Center
Hematology/oncology

2.Donna Mcnamara Md

225 Minnisink Rd
Totowa Nj 07512-1804
Totowa Cancer Center
Hematology/oncology

3.Elias Obeid Md

225 Minnisink Rd
Totowa Nj 07512-1804
Totowa Cancer Center
Hematology/oncology

View all 3 members of Totowa Cancer Center medical group